Opsonix picks up $8 mln Series A

By Iris Dorbian — 4 months ago

Cambridge, Massachusetts-based Opsonix, a developer of pathogen-extracting treatments focused on treating blood borne infectious diseases, has launched with $8 million in Series A funding. Baxter Ventures led the round.


Zytoprotec Secures Funds from Baxter Ventures

By Angela Sormani — 3 years ago

Zytoprotec, a company developing novel peritoneal dialysis solutions and other treatments based on active cytoprotection, has raised 2 million euros ($2.7 million) from new investor Baxter Ventures. The funding goes towards a 4 million euros Series A financing.